(Q36424620)

14 August 2017

1 reference

title

Angiogenesis--a new target for future therapy (English)

1 reference

14 August 2017

1 reference

Nilesh M Pandya

1

1 reference

14 August 2017

Naranjan S Dhalla

series ordinal

2

1 reference

14 August 2017

Dev D Santani

series ordinal

3

1 reference

14 August 2017

publication date

20 March 2006

1 reference

14 August 2017

published in

Vascular Pharmacology

1 reference

14 August 2017

volume

44

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

265-274

1 reference

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Vascular endothelial growth factor and microvascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Role of the microcirculation in the treatment and pathogenesis of psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Ultrastructure of the capillary loops in the dermal papillae of psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Clinical applications of angiogenic growth factors and their inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

The biology of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Angiogenesis in cancer, vascular, rheumatoid and other disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Researchers and regulators reflect on first gene therapy death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Inhibition of angiogenesis decreases alveolarization in the developing rat lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Tumor angiogenesis: past, present and the near future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Clinical translation of angiogenesis inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Review: angiogenesis: implications for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Association of hypoadiponectinemia with coronary artery disease in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Vascular endothelial growth factor is a secreted angiogenic mitogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Cancer research. Obstacle for promising cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Adiponectin and Metabolic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Specific increase in sensitivity to serotonin of the canine hindlimb collateral arterial tree via the 5-hydroxytryptamine-2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Association of hypoadiponectinemia with impaired vasoreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Angiogenesis in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Therapeutic angiogenesis in cardiology using protein formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Platelets, endothelium, and vasospasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Angiogenesis in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Capillary surface area is reduced and tissue thickness from capillaries to myocytes is increased in the left ventricle of streptozotocin-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Obesity is associated with impaired coronary collateral vessel development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Effect of p53 status on tumor response to antiangiogenic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.01.005

10.1016/J.VPH.2006.01.005

7 January 2021

Identifiers

DOI

1 reference

release_2ph4f2pv5nax3myvy6tuj3ys7i

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2ph4f2pv5nax3myvy6tuj3ys7i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference